Free Trial
→ The REAL Reason Trump is Invading Iran (From Banyan Hill Publishing) (Ad)tc pixel Free VACBF Stock Alerts

Nykode Therapeutics AS (VACBF) Short Interest Ratio & Short Volume

$0.38 0.00 (0.00%)
As of 05/13/2026
Compare

Nykode Therapeutics AS Short Interest Overview

As of April 30, 2026, Nykode Therapeutics AS (VACBF) had a short interest of 41,779 shares sold short. This marks a 0.00% change in short interest since the prior report. The short interest ratio (days to cover) is 0.0, meaning it would take 0.0 days of the average trading volume of 7,184 shares to cover all short positions.

Current Short Interest
41,779 shares
Previous Short Interest
41,779 shares
Change Vs. Previous Month
0.00%
Dollar Volume Sold Short
$15.88 thousand
Short Interest Ratio
0.0 Days to Cover
Last Record Date
April 30, 2026
Today's Trading Volume
0 shares
Average Trading Volume
7,184 shares
Today's Volume Vs. Average
0%
Short Selling Nykode Therapeutics AS?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Nykode Therapeutics AS and its competitors with MarketBeat's FREE newsletter.

Get Report
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

VACBF Short Interest Over Time

VACBF Days to Cover Over Time

VACBF Percentage of Float Shorted Over Time

Nykode Therapeutics AS Tesla Short Interest History & Recent Changes

Export
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/202641,779 shares $15.88 thousand No ChangeN/A0 $0.38
4/15/202641,779 shares $15.88 thousand -87.3%N/A0 $0.38
3/31/2026329,150 shares $125.08 thousand -55.7%N/A0 $0.38
3/13/2026743,685 shares $282.60 thousand -29.8%N/A0 $0.38
2/27/20261,059,580 shares $402.64 thousand -14.2%N/A0 $0.38
2/13/20261,235,218 shares $469.38 thousand -7.3%N/A999.99 $0.38
1/30/20261,333,019 shares $413.24 thousand -7.0%N/A661.88 $0.31
1/15/20261,432,566 shares $223.12 thousand No ChangeN/A0 $0.16
12/31/20251,432,566 shares $223.19 thousand -4.3%N/A999.99 $0.16
12/15/20251,497,204 shares $281.47 thousand -14.3%N/A0 $0.19
11/28/20251,746,531 shares $328.35 thousand No ChangeN/A0 $0.19
11/14/20251,746,531 shares $328.35 thousand No ChangeN/A0 $0.19
10/31/20251,746,531 shares $328.35 thousand No ChangeN/A628.7 $0.19
10/15/20251,746,500 shares $349.30 thousand No ChangeN/A129.4 $0.20
9/30/20251,746,500 shares $349.30 thousand 0.0%N/A970.3 $0.20
9/15/20251,747,000 shares $365.12 thousand No ChangeN/A0 $0.21
8/31/20251,747,000 shares $365.12 thousand +0.0%N/A0 $0.21
8/15/20251,746,500 shares $365.02 thousand No ChangeN/A759.3 $0.21
7/31/20251,746,500 shares $300.40 thousand -0.1%N/A17465 $0.17
7/15/20251,748,200 shares $340.90 thousand +0.1%N/A5827.3 $0.20
6/30/20251,746,800 shares $357.40 thousand No ChangeN/A0 $0.20
6/15/20251,746,800 shares $357.40 thousand -15.8%N/A17468 $0.20
5/31/20252,073,400 shares $475.02 thousand -4.1%N/A123.4 $0.23
5/15/20252,161,700 shares $649.81 thousand No ChangeN/A1441.1 $0.30
4/30/20252,161,700 shares $594.25 thousand No ChangeN/A21617 $0.27
4/15/20252,161,700 shares $469.09 thousand No ChangeN/A0 $0.22
3/31/20252,161,700 shares $469.09 thousand No ChangeN/A0 $0.22
3/15/20252,161,700 shares $469.09 thousand -0.9%N/A0 $0.22
2/28/20252,181,300 shares $473.34 thousand -0.6%N/A21813 $0.22
2/15/20252,193,400 shares $528.17 thousand +83.1%N/A0 $0.24
1/31/20251,197,800 shares $288.43 thousand -45.6%N/A0 $0.24
1/15/20252,199,700 shares $529.69 thousand -1.8%N/A0 $0.24
12/31/20242,239,800 shares $539.34 thousand No ChangeN/A0 $0.24
12/15/20242,239,800 shares $539.34 thousand +2.7%N/A0 $0.24
11/30/20242,180,200 shares $524.99 thousand -1.0%N/A908.4 $0.24
11/15/20242,203,200 shares $694.01 thousand -0.3%N/A4406.4 $0.32
10/31/20242,210,700 shares $1.15 million No ChangeN/A0 $0.52
10/15/20242,210,700 shares $1.15 million -1.9%N/A0 $0.52
9/30/20242,252,400 shares $1.17 million -2.2%N/A0 $0.52
9/15/20242,303,400 shares $1.20 million -2.9%N/A23034 $0.52
Elon Musk’s $1 Quadrillion AI IPO (Ad)

$1 quadrillion would be enough to send a $2.8 million check to every man, woman, and child in America. That is the scale of what analysts are calling the biggest AI IPO in history.And right now, you can claim a stake before the company goes public, starting with just $500.Elon Musk is predicting this investment could climb 1,000x from here. Early access is available today.tc pixel

Claim Your Stake Now
8/31/20242,371,000 shares $1.25 million +2.2%N/A3951.7 $0.53
8/15/20242,319,400 shares $3.48 million +1.1%N/A0 $1.50
7/31/20242,294,900 shares $3.44 million +10.4%N/A0 $1.50
7/15/20242,078,700 shares $3.12 million +5.1%N/A0 $1.50
6/30/20241,977,700 shares $2.97 million -1.2%N/A0 $1.50
6/15/20242,002,400 shares $3.00 million No ChangeN/A0 $1.50
5/31/20242,002,400 shares $3.00 million +7.9%N/A0 $1.50
5/15/20241,855,700 shares $2.78 million -0.6%N/A976.7 $1.50
4/30/20241,866,300 shares $2.33 million +6.7%N/A0 $1.25
4/15/20241,748,600 shares $2.19 million +7.7%N/A17486 $1.25
3/31/20241,623,000 shares $2.56 million -14.0%N/A16230 $1.58
3/15/20241,887,300 shares $2.98 million +77.3%N/A419.4 $1.58
2/29/20241,064,500 shares $1.68 million -9.1%N/A0 $1.58
2/15/20241,171,600 shares $1.85 million +26.3%N/A0 $1.58
1/15/2024768,100 shares $1.21 million +15.5%N/A0 $1.58
12/31/2023664,800 shares $1.05 million +12.1%N/A0 $1.58
12/15/2023593,100 shares $937.10 thousand No ChangeN/A0 $1.58
11/30/2023593,100 shares $937.10 thousand -30.2%N/A0 $1.58
11/15/2023849,200 shares $1.34 million -67.0%N/A0 $1.58
10/31/20232,576,500 shares $4.07 million -0.1%N/A25765 $1.58
10/15/20232,578,600 shares $5.80 million +5.3%N/A25786 $2.25
9/30/20232,448,000 shares $5.78 million +0.9%N/A0 $2.36
9/15/20232,426,800 shares $5.73 million +1.9%N/A0 $2.36
8/31/20232,382,800 shares $5.62 million No ChangeN/A0 $2.36

VACBF Short Interest - Frequently Asked Questions

Short interest is the volume of Nykode Therapeutics AS shares that have been sold short but have not yet been closed out or covered. As of April 30th, traders have sold 41,779 shares of VACBF short. Learn More on Nykode Therapeutics AS's current short interest.

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($86.09 billion), Invesco QQQ ($39.89 billion), iShares Russell 2000 ETF ($26.13 billion), Western Digital Corporation ($12.66 billion), Salesforce Inc. ($12.29 billion), Sandisk Corporation ($11.87 billion), SPDR S&P Biotech ETF ($9.82 billion), Lumentum Holdings Inc. ($8.51 billion), iShares 20+ Year Treasury Bond ETF ($7.76 billion), and Bloom Energy Corporation ($7.40 billion). View all of the most shorted stocks.

Short selling VACBF is an investing strategy that aims to generate trading profit from Nykode Therapeutics AS as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Nykode Therapeutics AS occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VACBF, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VACBF, twice per month. The most recent reporting period available is April, 30 2026.

Understanding short interest metrics can help you assess how traders are positioning around a stock like VACBF:

  • Shares Sold Short: The total number of shares that have been sold by short sellers but have not yet been covered or closed out. A high number may indicate bearish sentiment.
  • Short Float: The percentage of a company’s publicly available shares (or "float") that are sold short. A higher short float suggests a greater portion of the stock is being bet against.
  • Days to Cover (Short Interest Ratio): This estimates how many days it would take short sellers to cover their positions, based on average daily trading volume. Higher values can signal potential for a short squeeze if buying pressure increases.

These metrics are often used by traders to gauge sentiment, volatility risk, and the potential for price movements based on short covering activity.


Related Companies
Short Interest Tools

This page (OTCMKTS:VACBF) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners
SpaceX eyes a 1.75 trillion valuation - here's what to know
Elon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...
Brownstone Research | Sponsoredtc pixel
$30 stock to buy before Starlink goes public (WATCH NOW!)
In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...
Paradigm Press | Sponsoredtc pixel
Iran's New Leader Just Said Something That Should Terrify Every American
Iran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...
American Alternative | Sponsoredtc pixel
Your book attached
Your Download Link (Expiring) If you still haven't downloaded the free Simple Options Trading For Beginners...
Profits Run | Sponsoredtc pixel
My feud with Zohran Mamdani
Emmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...
Stansberry Research | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Why this tiny stock may move before the SpaceX IPO drops
The projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...
Behind the Markets | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel